- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT00416481
Assessing Older Patients With Cancer
Development of a Geriatric Assessment Measure for Older Patients With Cancer
RATIONALE: Questionnaires that measure the ability of older patients to think, learn, remember, and make judgments and carry out daily activities may improve the ability to plan treatment for patients with cancer.
PURPOSE: This clinical trial is studying ways to assess older patients with cancer.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
OBJECTIVES:
Primary
- Determine the feasibility of administration of the geriatric assessment in elderly patients with cancer.
- Determine the percentage of patients able to complete the self-administered portion of the geriatric assessment without assistance.
- Determine the length of time necessary to complete the geriatric assessment.
- Determine the variance and number of missing items.
- Assess patient satisfaction with the questionnaire by identifying items that are distressing or difficult to comprehend.
- Assess the percentage of geriatric assessments that contain all three of the following items: Timed Up and Go Assessment, Blessed Orientation-Memory-Concentration Test, and healthcare professional-rated Karnofsky performance status.
Secondary
- Determine the proportion of patients who are able to complete the self-report portion of the questionnaire without assistance and the length of time needed to complete the geriatric assessment within patients of various sociodemographic factors and educational status.
OUTLINE: This is a multicenter study. Patients are stratified according to age (65 to 69 years vs 70 years and over).
Patients undergo assessments of cognition using the Blessed Orientation-Memory-Concentration Test; functional status using the Timed Up and Go Assessment (measures physical mobility); and performance status using the healthcare professional-rated Karnofsky performance scale. These assessments are performed by healthcare personnel. Body mass index and the percentage of unintentional weight loss and the number of falls in the past 6 months are also assessed.
Patients also complete the following self-administered questionnaires: Instrumental Activities of Daily Living (measures level of functioning and need for services); Activities of Daily Living (measures higher levels of physical functioning); Karnofsky Self-Reported Performance Rating Scale (related to survival and clinically significant illness); Physical Health Section of the Older American Resources and Services Questionnaire (measures comorbidity and the impact on daily activities); Hospital Anxiety and Depression Scale; Medical Outcomes Study (MOS) Social Activity Limitations Measure (measures the impact of cancer on patients' social functioning); and MOS Social Support Survey Emotional/Information and Tangible Subscales (measures perceived availability of social support).
Patients then begin planned treatment.
Type d'étude
Inscription (Réel)
Contacts et emplacements
Lieux d'étude
-
-
Indiana
-
Elkhart, Indiana, États-Unis, 46515
- Elkhart General Hospital
-
Kokomo, Indiana, États-Unis, 46904
- Howard Community Hospital
-
La Porte, Indiana, États-Unis, 46350
- Center for Cancer Therapy at LaPorte Hospital and Health Services
-
South Bend, Indiana, États-Unis, 46601
- Memorial Hospital of South Bend
-
South Bend, Indiana, États-Unis, 46601
- CCOP - Northern Indiana CR Consortium
-
South Bend, Indiana, États-Unis, 46617
- Saint Joseph Regional Medical Center
-
South Bend, Indiana, États-Unis, 46601
- Michiana Hematology-Oncology, PC - South Bend
-
-
Michigan
-
St. Joseph, Michigan, États-Unis, 49085
- Lakeland Regional Cancer Care Center - St. Joseph
-
-
Nevada
-
Las Vegas, Nevada, États-Unis, 89102
- University Medical Center of Southern Nevada
-
Las Vegas, Nevada, États-Unis, 89106
- CCOP - Nevada Cancer Research Foundation
-
-
New York
-
East Syracuse, New York, États-Unis, 13057
- CCOP - Hematology-Oncology Associates of Central New York
-
-
North Carolina
-
Durham, North Carolina, États-Unis, 27710
- Duke Comprehensive Cancer Center
-
-
Ohio
-
Columbus, Ohio, États-Unis, 43210-1240
- Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
La description
DISEASE CHARACTERISTICS:
- Histologically confirmed malignancy at any stage
- Enrolled on any cooperative group-sponsored cancer treatment trial (treatment has not yet started), including trials on the Cancer Trials Support Unit
PATIENT CHARACTERISTICS:
- Any performance status allowed
- Must be able to follow directions in English
- Sufficient cognitive and psychological function to give consent
PRIOR CONCURRENT THERAPY:
- See Disease Characteristics
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
Cohortes et interventions
Groupe / Cohorte |
Intervention / Traitement |
|---|---|
|
Patient assessment
Patients undergo assessments of cognition and performance status using the healthcare professional-rated Karnofsky performance scale. These assessments are performed by healthcare personnel. Body mass index and the percentage of unintentional weight loss and the number of falls in the past 6 months are also assessed. Patients also complete self-administered questionnaires that measure level of functioning and need for services. It also includes questionnaires that measure higher levels of physical functioning, performance related to survival and clinically significant illness and measures of comorbidity and the impact on daily activities. Lastly, questionnaires are administered to measure the impact of cancer on patients' social functioning and perceived availability of social support. Patients then begin planned treatment. |
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Mean and median time to complete the entire geriatric assessment
Délai: Up to 3 years
|
Up to 3 years
|
|
Mean number of missing items in each subscale and the distribution of missing items
Délai: Up to 3 years
|
Up to 3 years
|
|
Percentage of patients who identify a scale to be upsetting or difficult to understand
Délai: Up to 3 years
|
Up to 3 years
|
|
Percentage of Geriatric Assessments for which all three items (Timed Up and Go Assessment, Blessed Orientation-Memory-Concentration Test, and the healthcare professional-rated Karnofsky performance status) are completed
Délai: Up to 3 years
|
Up to 3 years
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chaise d'étude: Alice B. Kornblith, PhD, Dana-Farber Cancer Institute
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Réel)
Achèvement de l'étude (Réel)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Autres numéros d'identification d'étude
- CALGB-360401
- CDR0000523527 (Identificateur de registre: NCI Physician Data Query)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .